Quadrant Capital Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
|
|||||
|
2025
Q1 | $304K | Buy |
|
|||||
|
2024
Q4 | $96.5K | Buy |
|
|||||
|
2024
Q3 | $61.8K | Buy |
|
|||||
|
2024
Q2 | $39.4K | Buy |
|
|||||
|
2024
Q1 | $28.8K | Buy |
|
|||||
|
2023
Q4 | $15.6K | Sell |
|
|||||
|
2023
Q3 | $24.1K | Buy |
|
|||||
|
2023
Q2 | $2.71K | Sell |
|
|||||
|
2023
Q1 | $15K | Buy |
|
|||||
|
2022
Q4 | $11.7K | Buy |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $8K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $9K | Buy |
|
|||||
|
2021
Q3 | $4K | Buy |
|
|||||
|
2021
Q2 | $3K | Sell |
|
|||||
|
2021
Q1 | $4K | Buy |
|
|||||
|
2020
Q4 | $3K | Buy |
|
|||||
|
2020
Q3 | $1K | Sell |
|
|||||
|
2020
Q2 | $2K | Sell |
|
|||||
|
2020
Q1 | $137K | Buy |
|
|||||
|
2019
Q4 | $133K | Buy |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $120K | Buy |
|
|||||
|
2019
Q1 | $104K | Buy |
|
|||||
|
2018
Q4 | $80K | Buy |
|
|||||
|
2018
Q3 | $19K | Buy |
|
|||||
|
2018
Q2 | $15K | Sell |
|
|||||
|
2018
Q1 | $11K | Buy |
|
|||||
|
2017
Q4 | $4K | Sell |
|
|||||
|
2017
Q3 | $4K | Sell |
|
|||||
|
2017
Q2 | $12K | Sell |
|
|||||
|
2017
Q1 | $21K | Buy |
|
|||||
|
2016
Q4 | $13K | Sell |
|
|||||
|
2016
Q3 | $90K | Buy |
|
|||||
|
2016
Q2 | $37K | Sell |
|
|||||
|
2016
Q1 | $96K | Sell |
|
|||||
|
2015
Q4 | $167K | Buy |
|
|||||
|
2015
Q3 | $132K | Buy |
|
|||||
|
2015
Q2 | $80K | Buy |
|